Pure Global AI
NCT06337279Completed

Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk

The Clinical Value of Systemic Oxidative Stress Score in Predicting Long-term Survival and Recurrence Risk in Gastric Cancer: A Multicenter Real-world Cohort Study
Fujian Medical UniversityClinicalTrials.gov
Verified
Study focus
Disease/Condition
Gastric Cancer
Study type
Observational
Sponsor & location
Primary sponsor
Fujian Medical University
Location
Fuzhou, China
Timeline & enrollment
Phase
N/A
Start date
Dec 10, 2022
End date
Mar 20, 2024
Enrollment
3820 participants
Primary outcome

5-year OS,5-year DFS

Summary

The Systemic Oxidative Stress Score (SOSS) , a comprehensive score reflecting the oxidative
 stress conditions in the microenvironment, can independently and effectively predict tumor
 burden and long-term prognosis in GC patients. Nomograms based on SOSS provide a potential
 and promising model for risk stratification and guiding the implementation of treatment
 decisions.

ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06337279
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06337279 through Pure Global AI's free database. This phase not specified trial is sponsored by Fujian Medical University and is currently Completed. The study focuses on Gastric Cancer. Target enrollment is 3820 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.